# Metabolic Consequences of Cross-sex Hormonal Treatment

> **NCT04508231** · — · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 98 (estimated)

## Conditions studied

- Gender Dysphoria

## Interventions

- **OTHER:** Gender-affirming hormone therapy

## Key facts

- **NCT ID:** NCT04508231
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-24
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04508231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04508231, "Metabolic Consequences of Cross-sex Hormonal Treatment". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04508231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*